World Health Day: Explore 7 Active Clinical Trials Driving Medical Progress
Every aspect of our lives—how we feel, function, and grow—is closely tied to our health. World Health Day serves as a reminder of the importance of accessible, equitable healthcare and the systems that support it worldwide.
Each year, the day brings attention to key health challenges and the need for solutions that reach people where they are. From managing chronic conditions to improving early diagnosis and treatment options, access remains a central part of the conversation.
Clinical research plays an important role in this progress. It helps improve our understanding of diseases and supports the development of new and more effective treatments. However, for many, identifying relevant clinical trials can still be a complex process. At TrialX, we aim to make clinical research more accessible by helping individuals discover studies that align with their health profile and location.
This World Health Day, we’re spotlighting 7 clinical trials currently recruiting participants.
1. Assessment of AI Program ‘DRISTi’ as a Screening Tool for Diabetic Retinopathy
Sponsor: Artelus AI
What It’s Testing and Why It Matters
This study is evaluating an artificial intelligence (AI) program called DRISTi to see how accurately it can detect diabetic retinopathy using eye images. Participants with diabetes will have retinal images taken through a standard imaging process. These images are then analyzed by the AI software and compared with assessments from an ophthalmic reading center. The goal is to understand whether the AI system can reliably identify signs of diabetic eye disease, which is a common complication of diabetes and can lead to vision loss if not detected early.
Why It Stands Out
This study focuses on using AI as a screening tool, which could help simplify and speed up the process of identifying eye-related complications in people with diabetes. By comparing AI results with expert evaluations, the study aims to validate whether this technology can be used more widely in clinical settings.
What It Could Mean for Patients
If successful, this study could:
- Support earlier detection of diabetic eye conditions
- Improve access to screening, especially in settings with limited specialists
- Help streamline routine eye check-ups for people with diabetes
Locations: This study is recruiting in the United States, with sites in North Carolina, including Oxford and Raleigh.
Learn more about the study and check your eligibility here.
2. Coordination of Rare Diseases at Sanford (CoRDS): Rare Disease Patient Registry
Sponsor: Sanford Health
What It’s Testing and Why It Matters
This study is building a large, centralized patient registry for individuals with rare, undiagnosed, or uncommon conditions. Participants can enroll and share information about their health, diagnosis, and background, which is then securely stored and made available (in a de-identified format) to approved researchers.
The goal is to make it easier for researchers to study rare diseases by connecting them with patient data in one place. With over 7,000 rare diseases identified globally, collecting and organizing this information is an important step toward improving understanding and research.
Why It Stands Out
Unlike traditional clinical trials, this is an ongoing registry that supports long-term research across many rare conditions. It is open to participants of all ages and allows individuals from different locations to contribute. The registry also works with patient advocacy groups and research organizations to support collaboration and avoid duplication of efforts.
What It Could Mean for Patients
For individuals living with a rare or undiagnosed condition, opportunities to contribute to research can be limited. This registry offers a way to be part of ongoing efforts to better understand these conditions, even without participating in a traditional clinical trial. Over time, this kind of data can support new studies, improve awareness, and help guide future research directions.
Locations: Participants can enroll remotely, with coordination based in the United States (Sanford Research, South Dakota).
You can explore more details about the trial here.
3. A Vaccine Trial for Low-Grade Gliomas
Sponsor: University of Pittsburgh
What It’s Testing and Why It Matters
This study is evaluating a vaccine-based approach for children and young adults with low-grade gliomas that cannot be removed through surgery and have already been treated with other therapies. The treatment combines specific glioma-related peptides with an immune-stimulating agent (poly-ICLC) to help the body recognize and respond to tumor cells. Participants receive a series of injections over several weeks, with follow-up scans to monitor how the tumor responds.
Why It Stands Out
This trial focuses on a targeted immunotherapy approach rather than traditional treatments alone. By training the immune system to respond to tumor-specific markers, it explores a more personalized way of managing certain brain tumors. The study also focuses on a younger population, where treatment options can be more limited.
What It Could Mean for Patients
For families navigating recurrent or hard-to-treat tumors, options can sometimes feel limited. This study is part of ongoing efforts to explore new approaches that work differently from standard treatments. It may also help researchers better understand how vaccine-based therapies can be used in similar conditions in the future.
Locations: This study is recruiting in the United States at the Children’s Hospital of Pittsburgh, Pennsylvania.
Learn more details about participation and eligibility here.
4. ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
Sponsor: University of Florida
What It’s Testing and Why It Matters
This study is evaluating different strategies to improve HPV vaccination rates among children in rural communities. Instead of focusing on a single intervention, it looks at how combining multiple approaches—targeting clinicians, parents, and healthcare access—can influence vaccination uptake. The study is designed as a three-arm trial where clinics are assigned to receive clinician training alone, training plus parent-focused support like reminders and motivational calls, or a combination of these with additional access support such as transportation and mobile vaccination clinics.
Why It Stands Out
This trial focuses on how care is delivered rather than testing a new drug or vaccine. By addressing barriers at multiple levels—provider communication, parental decision-making, and access to care—it reflects the real-world challenges that often affect vaccination rates in rural settings. The structured, stepwise design also allows researchers to understand which combination of strategies is most effective.
What It Could Mean for Patients
For families in rural areas, challenges like limited access to clinics, transportation, or clear information can affect preventive care decisions. This study is part of broader efforts to understand how those gaps can be reduced through coordinated support.
It may also provide insights into how similar approaches could be applied to other preventive health programs in underserved communities.
Locations: This study is recruiting in the United States at sites in Florida, including Gainesville.
Learn more about the study here
5. Triage Survey for Infectious Disease Eligibility
Sponsor: Brooklyn Clinical Research
What It’s Testing and Why It Matters
This study is designed to evaluate how potential participants can be identified and matched to future clinical trials focused on infectious diseases. Rather than testing a treatment, this is a large-scale survey and screening effort. Participants go through a structured process that includes informed consent, medical history review, and basic health assessments such as vital signs, lab tests, and questionnaires. A physician then reviews this information to determine whether an individual may be eligible for upcoming clinical trials.
The study is also tracking how many people who express interest in research are ultimately eligible and go on to enroll in trials.
Why It Stands Out
This study focuses on the step before trial participation—identifying and preparing eligible participants. Recruitment and screening are often major bottlenecks in clinical research, especially in infectious disease studies. By standardizing this triage process, the study aims to better understand common barriers to eligibility and improve how participants are matched to relevant trials.
What It Could Mean for Patients
For individuals interested in participating in clinical research, this approach could make it easier to understand eligibility and connect with appropriate studies. It may also help reduce delays in trial enrollment by creating a more structured pathway from initial interest to participation, particularly in areas like infectious diseases, where timely recruitment can be important.
Locations: This study is recruiting in the United States at a site in Brooklyn, New York.
Check out more about eligibility here.
6. Does Social Media Impact Adolescent Mental Health?
Sponsor: Georgetown University
What It’s Testing and Why It Matters
This study is examining whether social media has a direct impact on adolescent mental health. While rising rates of anxiety and depression among teens have been widely discussed, it remains unclear whether social media is a contributing cause or simply correlated with these trends. To explore this, the study uses a randomized design where participants are assigned to either continue their normal social media use or have social media access restricted for a period of time. Researchers then compare changes in mental health outcomes, including symptoms of anxiety and depression, across both groups.
Why It Stands Out
This study takes an experimental approach to a question that is often studied through observational data. By limiting social media use for one group and comparing outcomes, it moves closer to identifying cause-and-effect relationships rather than associations. It also combines survey data with passive mobile sensing—such as tracking app usage and interaction patterns—to capture both behavior and mental health changes over time.
What It Could Mean for Patients
For families and adolescents navigating questions around screen time and mental well-being, clearer evidence could help inform decisions about social media use. The findings may also contribute to broader discussions around digital environments, mental health, and how young people interact with technology during key developmental stages.
Locations: This study is recruiting in the United States at Georgetown University in Washington, D.C.
Find out more details about participation and eligibility here.
7. SMARTer Weight Loss Management (SMARTer)
Sponsor: Northwestern University
What It’s Testing and Why It Matters
This study is evaluating a new, adaptive weight loss approach called SMARTer and comparing it to the standard Diabetes Prevention Program (DPP) and a self-guided option. The goal is to see whether a more flexible, step-by-step intervention can achieve similar weight loss results while reducing costs.
Participants are assigned to one of three groups: the SMARTer program, the traditional DPP, or a self-guided approach. Over time, the SMARTer program adjusts the level of support—starting with basic tools like an app and coaching, and increasing intensity only if participants are not meeting weight loss goals.
Why It Stands Out
Unlike one-size-fits-all programs, this study tests a stepped-care model—meaning support is tailored based on individual progress. Instead of giving everyone the same level of intervention, resources are used more efficiently by focusing additional support only where it’s needed.
It also goes beyond effectiveness to evaluate cost and affordability, which is often missing in behavioral health research but critical for scaling real-world solutions.
What It Could Mean for Patients
For individuals trying to lose weight, structured programs can sometimes feel intensive or hard to sustain. This study explores whether a more personalized, flexible approach can deliver similar results with less burden. If successful, it could lead to more accessible and cost-effective weight management programs that adapt to people’s needs.
Locations: This study is recruiting in the United States at Northwestern University in Chicago, Illinois.
Learn more about eligibility here.
Supporting Better Health Through Research
Clinical research continues to shape how we understand health and disease across different areas—from prevention and behavior to treatment and long-term care. As studies explore new approaches and real-world challenges, they help build clearer, more practical ways to improve health outcomes for individuals and communities alike.
If you’re interested in learning more about clinical trials, explore currently recruiting studies through TrialX or sign up to our volunteer registry to receive updates on studies that may be relevant to you.
For additional information and resources, you can also visit organizations like the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and UNICEF.
